Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Hazleman

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
British Journal of Rheumatology|April 1, 1990
Why is a frozen shoulder frozen?B Hazleman
The American Journal of Medicine|January 21, 1985
Incidence of neoplasms in patients with rheumatoid arthritis exposed to different treatment regimensB Hazleman
British Journal of Rheumatology|October 1, 1990
Why is the supraspinatus tendon such a common site for calcification?B Hazleman
British Journal of Rheumatology|February 1, 1991
What is your policy for weaning polymyalgia rheumatica patients from corticosteroids after 2 years? How do you know when to stop the process, if at all?B Hazleman
Clinical and Experimental Rheumatology|August 19, 2000
Laboratory investigations useful in the evaluation of polymyalgia rheumatica (PMR) and giant cell arteritis (GCA)B Hazleman
British Journal of Rheumatology|April 1, 1997
Erythrocyte sedimentation rate (ESR) at presentation is a prognostic indicator for duration of treatment in polymyalgia rheumatica (PMR)G Pountain, B Hazleman
Lancet (London, England)|July 30, 1983
Prostaglandin E-1 and peripheral vascular diseaseV Kyle, B Hazleman
Clinical and Experimental Rheumatology|April 1, 1985
Credibility of placebo transcutaneous nerve stimulation and acupunctureJ Petrie, B Hazleman
BMJ (Clinical Research Ed.)|April 22, 1995
ABC of rheumatology. Polymyalgia rheumatica and giant cell arteritisG Pountain, B Hazleman
Current Medical Research and Opinion|January 1, 1993
Acemetacin in the long-term therapy of rheumatoid arthritisB Hazleman, R M Bernstein
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
British Journal of Rheumatology|April 1, 1990
Why is a frozen shoulder frozen?B Hazleman
The American Journal of Medicine|January 21, 1985
Incidence of neoplasms in patients with rheumatoid arthritis exposed to different treatment regimensB Hazleman
British Journal of Rheumatology|October 1, 1990
Why is the supraspinatus tendon such a common site for calcification?B Hazleman
British Journal of Rheumatology|February 1, 1991
What is your policy for weaning polymyalgia rheumatica patients from corticosteroids after 2 years? How do you know when to stop the process, if at all?B Hazleman
Clinical and Experimental Rheumatology|August 19, 2000
Laboratory investigations useful in the evaluation of polymyalgia rheumatica (PMR) and giant cell arteritis (GCA)B Hazleman
British Journal of Rheumatology|April 1, 1997
Erythrocyte sedimentation rate (ESR) at presentation is a prognostic indicator for duration of treatment in polymyalgia rheumatica (PMR)G Pountain, B Hazleman
Lancet (London, England)|July 30, 1983
Prostaglandin E-1 and peripheral vascular diseaseV Kyle, B Hazleman
Clinical and Experimental Rheumatology|April 1, 1985
Credibility of placebo transcutaneous nerve stimulation and acupunctureJ Petrie, B Hazleman
BMJ (Clinical Research Ed.)|April 22, 1995
ABC of rheumatology. Polymyalgia rheumatica and giant cell arteritisG Pountain, B Hazleman
Current Medical Research and Opinion|January 1, 1993
Acemetacin in the long-term therapy of rheumatoid arthritisB Hazleman, R M Bernstein
Pageof 5